Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer
- PMID: 25224155
- PMCID: PMC4176577
- DOI: 10.1186/1471-2407-14-672
Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer
Abstract
Background: The Prognostic value of microvessel density in cancer remains unclear. Recent studies have suggested that the uneven distribution of microvessels in tumours caused the variation in sample selection which led to different prognostic outcome. The enhancement pattern of Contrast-enhanced computed tomography (CECT) is determined in part by the microvessel distribution in solid tumors. Therefore, survival analysis of tumors grouping by the enhancement pattern and the pattern of microvessel distribution is important.
Methods: Survival analysis grouped by the tumor enhancement pattern and the microvessel distribution was carried out in 255 patients with invasive ductal carcinoma.
Results: There were significant differences in overall survival (OS) and disease-free survival (DFS) among the homogeneous, heterogeneous and peripheral enhancement groups. There were significant differences between OS and DFS groups with uniform and uneven distributions of microvessels.
Conclusions: The distribution of microvessels in a tumor is a potential prognostic indicator in patients with breast cancer, and can be assessed by CECT prior the operation.
Figures



Similar articles
-
Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.Asian Pac J Cancer Prev. 2013;14(3):1715-20. doi: 10.7314/apjcp.2013.14.3.1715. Asian Pac J Cancer Prev. 2013. PMID: 23679262 Clinical Trial.
-
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.J Natl Cancer Inst. 1995 Jul 5;87(13):997-1008. doi: 10.1093/jnci/87.13.997. J Natl Cancer Inst. 1995. PMID: 7543156
-
Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.Turk Patoloji Derg. 2016;32(3):164-70. doi: 10.5146/tjpath.2016.01366. Turk Patoloji Derg. 2016. PMID: 27562390 English.
-
Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer.Hum Pathol. 2013 Aug;44(8):1688-95. doi: 10.1016/j.humpath.2012.11.023. Epub 2013 Apr 8. Hum Pathol. 2013. PMID: 23574778
-
The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET/CT in patients with breast cancer.Eur J Radiol. 2018 Aug;105:1-7. doi: 10.1016/j.ejrad.2018.05.014. Epub 2018 May 17. Eur J Radiol. 2018. PMID: 30017264 Review.
Cited by
-
Prediction of Metastasis in the Axillary Lymph Nodes of Patients With Breast Cancer: A Radiomics Method Based on Contrast-Enhanced Computed Tomography.Front Oncol. 2021 Sep 20;11:726240. doi: 10.3389/fonc.2021.726240. eCollection 2021. Front Oncol. 2021. PMID: 34616678 Free PMC article.
-
Vessel size as a marker of survival in estrogen receptor positive breast cancer.Breast Cancer Res Treat. 2023 Jul;200(2):293-304. doi: 10.1007/s10549-023-06974-4. Epub 2023 May 24. Breast Cancer Res Treat. 2023. PMID: 37222874 Free PMC article.
-
Estrogen Receptor and Claudin-6 Might Play Vital Roles for Long-Term Prognosis in Patients With Luminal A Breast Cancer Who Underwent Neoadjuvant Chemotherapy.Front Oncol. 2022 Jun 30;12:630065. doi: 10.3389/fonc.2022.630065. eCollection 2022. Front Oncol. 2022. PMID: 35847894 Free PMC article.
-
Application of Machine Learning Algorithm in Predicting Axillary Lymph Node Metastasis from Breast Cancer on Preoperative Chest CT.Diagnostics (Basel). 2023 Sep 14;13(18):2953. doi: 10.3390/diagnostics13182953. Diagnostics (Basel). 2023. PMID: 37761320 Free PMC article.
-
Iodine map histogram metrics in early-stage breast cancer: prediction of axillary lymph node metastasis status.Quant Imaging Med Surg. 2022 Dec;12(12):5358-5370. doi: 10.21037/qims-22-253. Quant Imaging Med Surg. 2022. PMID: 36465827 Free PMC article.
References
-
- Nadkarni NJ, Geest KD, Neff T, Young BD, Bender DP, Ahmed A, Smith BJ, Button A, Goodheart MJ. Cancer Lett. 2012. Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer. - PubMed
-
- Tretiakova M, Antic T, Binder D, Kocherginsky M, Liao C, Taxy JB, Oto A. Hum Pathol. 2012. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. - PubMed
Pre-publication history
-
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/14/672/prepub
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous